Merkel cell carcinoma expresses vasculogenic mimicry: Demonstration in patients and experimental manipulation in xenografts

Laboratory Investigation

Volumn 94, Issue 10, 2014, Pages 1092-1102

  Lezcano, Cecilia ^a   Kleffel, Sonja ^b,c   Lee, Nayoung ^b,c   Larson, Allison R ^b,c   Zhan, Qian ^b,c   Rosario, Andrew Do ^b,c   Wang, Linda C ^d   Schatton, Tobias ^b,c,e   Murphy, George F ^b,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MERCY MEDICAL CENTER   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CD31 ANTIGEN; COMPLEMENTARY DNA; ETOPOSIDE; LAMININ; RNA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; ANTINEOPLASTIC AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; MERKEL CELL TUMOR; MOUSE; NOD SCID MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOMA; TUMOR XENOGRAFT; VASCULOGENIC MIMICRY; XENOTRANSPLANTATION; AGED; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, MERKEL CELL; KNOCKOUT MOUSE; LYMPH NODE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RANDOMIZATION; SKIN; SKIN NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION; UMBILICAL VEIN ENDOTHELIAL CELL; VERY ELDERLY; XENOGRAFT;

AGED; AGED, 80 AND OVER; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOPLATIN; CARCINOMA, MERKEL CELL; CELL LINE, TUMOR; ETOPOSIDE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYMPH NODES; MICE, KNOCKOUT; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; SKIN; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84921730572     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.99     Document Type: Article

References (52)

1. Akhtar S, Oza KK, Wright J. Merkel cell carcinoma: report of 10 cases and review of the literature. J Am Acad Dermatol 2000;43:755-767.
2. Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
3. Laga AC, Lai CY, Zhan Q, et al. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology. Am J Pathol 2010;176:903-913.
4. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008;451:345-349.
5. Frank NY, Schatton T, Kim S, et al. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 2011;71:1474-1485.
6. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-752.
7. Seftor EA, Meltzer PS, Kirschmann DA, et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 2002;19:233-246.
8. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
9. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
10. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998;94:715-725.
11. Bissell MJ. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name? Am J Pathol 1999;155:675-679.
12. Hendrix MJ, Seftor EA, Meltzer PS, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 2001;98:8018-8023.
13. Rodig SJ, Cheng J, Wardzala J, et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012;122:4645-4653.
14. Frank NY, Margaryan A, Huang Y, et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005;65:4320-4333.
15. Lian CG, Xu Y, Ceol C, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012;150:1135-1146.
16. Fichtner I, Rolff J, Soong R, et al. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res 2008;14:6456-6468.
17. McAllister JC, Zhan Q, Weishaupt C, et al. The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol 2010;37(Suppl 1):19-25.
18. Wilson BJ, Schatton T, Zhan Q, et al. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res 2011;71:5307-5316.
19. Shirakawa K, Kobayashi H, Heike Y, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 2002;62:560-566.
20. Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010;468:829-833.
21. Sun B, Zhang S, Zhao X, et al. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 2004;25:1609-1614.
22. Hendrix MJ, Seftor EA, Kirschmann DA, et al. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res 2000;2:417-422.
23. Liu R, Yang K, Meng C, et al. Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol Ther 2012;13: 527-533.
24. Chai DM, Bao ZQ, Hu JG, et al. Vasculogenic mimicry and aberrant expression of HIF-lalpha/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma. J Huazhong Univ Sci Technolog Med Sci 2013;33:385-391.
25. Lu XS, Sun W, Ge CY, et al. Contribution of the PI3K/MMPs/Ln-5gamma2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol 2013;42:2103-2115.
26. Wang SY, Ke YQ, Lu GH, et al. Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma. J Neurooncol 2013;112:339-345.
27. Yu L, Wu SW, Zhou L, et al. Correlation between bacterial L-form infection, expression of HIF-1alpha/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer. Sheng Li Xue Bao 2012;64:657-665.
28. Wu S, Yu L, Wang D, et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer 2012;12:535.
29. Lin P, Wang W, Sun BC, et al. Vasculogenic mimicry is a key prognostic factor for laryngeal squamous cell carcinoma: a new pattern of blood supply. Chin Med J (Engl) 2012;125:3445-3449.
30. Sun W, Shen ZY, Zhang H, et al. Overexpression of HIF-1alpha in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis. Oncol Rep 2012;27:1990-2002.
31. Wang SY, Yu L, Ling GQ, et al. Vasculogenic mimicry and its clinical significance in medulloblastoma. Cancer Biol Ther 2012;13:341-348.
32. Baeten CI, Hillen F, Pauwels P, et al. Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum 2009;52:2028-2035.
33. van Beurden A, Schmitz RF, van Dijk CM, et al. Periodic acid Schiff loops and blood lakes associated with metastasis in cutaneous melanoma. Melanoma Res 2012;22:424-429.
34. Kirschmann DA, Seftor EA, Hardy KM, et al. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res 2012;18:2726-2732.
35. Sun B, Zhang D, Zhang S, et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 2007;249:188-197.
36. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465.
37. Chartrain M, Riond J, Stennevin A, et al. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. PLoS One 2012; 7:e36762.
38. Cheung ST, Cheung PF, Cheng CK, et al. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 2011;140:344-355.
39. Chiao MT, Yang YC, Cheng WY, et al. CD133 glioblastoma stem-like cells induce vascular mimicry in vivo. Curr Neurovasc Res 2011;8: 210-219.
40. Hall PA, d'Ardenne AJ, Butler MG, et al. Cytokeratin and laminin immunostaining in the diagnosis of cutaneous neuro-endocrine (Merkel cell) tumours. Histopathology 1986;10:1179-1190.
41. Kukko H, Koljonen V, Lassus P, et al. Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma. Anticancer Res 2007;27:2587-2589.
42. Mortarini R, Gismondi A, Maggioni A, et al. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res 1995;55:4702-4710.
43. Panayotou G, End P, Aumailley M, et al. Domains of laminin with growth-factor activity. Cell 1989;56:93-101.
44. Bremnes RM, Donnem T, Al-Saad S, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 2011;6: 209-217.
45. Pouliot N, Kusuma N. Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis. Cell Adh Migr 2013;7:142-149.
46. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012;196:395-406.
47. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-381.
48. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39:469-478.
49. Vartanian A, Stepanova E, Grigorieva I, et al. VEGFR1 and PKCalpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Melanoma Res 2011;21:91-98.
50. Hendrix MJ, Seftor EA, Seftor RE, et al. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 2007;7:246-255.
51. Seftor RE, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001; 61:6322-6327.
52. Simon-Assmann P, Orend G, Mammadova-Bach E, et al. Role of laminins in physiological and pathological angiogenesis. Int J Dev Biol 2011;55:455-465.